Abbrea Capital’s Pfizer PFE Stock Holding History

Abbrea Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	$1.74M	Sell	62,142 -4,520	-7%	-$126K	0.23%	82
2024 Q1	$1.85M	Sell	66,662 -8,157	-11%	-$226K	0.24%	81
2023 Q4	$2.15M	Sell	74,819 -14,250	-16%	-$410K	0.31%	70
2023 Q3	$2.95M	Sell	89,069 -338	-0.4%	-$11.2K	0.47%	48
2023 Q2	$3.28M	Buy	89,407 +466	+0.5%	+$17.1K	0.5%	47
2023 Q1	$3.63M	Sell	88,941 -1,327	-1%	-$54.1K	0.62%	39
2022 Q4	$4.63M	Buy	90,268 +1,560	+2%	+$79.9K	0.83%	31
2022 Q3	$3.88M	Sell	88,708 -4,143	-4%	-$181K	0.73%	35
2022 Q2	$4.87M	Buy	92,851 +114	+0.1%	+$5.97K	0.81%	28
2022 Q1	$4.8M	Buy	92,737 +1,300	+1%	+$67.3K	0.67%	37
2021 Q4	$5.4M	Buy	91,437 +360	+0.4%	+$21.3K	0.73%	31
2021 Q3	$3.92M	Buy	91,077 +2,985	+3%	+$128K	0.58%	36
2021 Q2	$3.45M	Buy	88,092 +7,406	+9%	+$290K	0.52%	51
2021 Q1	$2.92M	Buy	80,686 +3,490	+5%	+$126K	0.48%	53
2020 Q4	$2.84M	Buy	77,196 +39	+0.1%	+$1.44K	0.51%	51
2020 Q3	$2.69M	Buy	77,157 +748	+1%	+$26K	0.57%	45
2020 Q2	$2.37M	Sell	76,409 -906	-1%	-$28.1K	0.54%	46
2020 Q1	$2.39M	Sell	77,315 -1,893	-2%	-$58.6K	0.64%	45
2019 Q4	$2.94M	Sell	79,208 -2,619	-3%	-$97.3K	0.63%	42
2019 Q3	$2.79M	Sell	81,827 -564	-0.7%	-$19.2K	0.65%	43
2019 Q2	$3.39M	Buy	82,391 +12,635	+18%	+$519K	0.83%	39
2019 Q1	$2.81M	Buy	69,756 +1,597	+2%	+$64.4K	0.81%	38
2018 Q4	$2.82M	Buy	68,159 +3,354	+5%	+$139K	0.93%	35
2018 Q3	$2.71M	Sell	64,805 -3,094	-5%	-$129K	0.8%	38
2018 Q2	$2.34M	Buy	67,899 +1,343	+2%	+$46.2K	0.73%	43
2018 Q1	$2.24M	Buy	66,556 +4,252	+7%	+$143K	0.73%	42
2017 Q4	$2.14M	Buy	62,304 +5,643	+10%	+$194K	0.73%	46
2017 Q3	$1.92M	Buy	56,661 +279	+0.5%	+$9.45K	0.71%	45
2017 Q2	$1.8M	Sell	56,382 -1,546	-3%	-$49.3K	0.72%	45
2017 Q1	$1.88M	Sell	57,928 -2,108	-4%	-$68.4K	0.77%	43
2016 Q4	$1.85M	Buy	+60,036	New	+$1.85M	0.87%	40